Independent effects of age and levodopa on reversal learning in healthy volunteers
- PMID: 29894903
- DOI: 10.1016/j.neurobiolaging.2018.05.014
Independent effects of age and levodopa on reversal learning in healthy volunteers
Abstract
The dopamine overdose hypothesis has provided an important theoretical framework for understanding cognition in Parkinson's disease. It posits that effects of dopaminergic therapy on cognition in Parkinson's disease depend on baseline dopamine levels in brain regions that support different functions. Although functions performed by more severely dopamine-depleted brain regions improve with medication, those associated with less dopamine deficient areas are actually worsened. It is presumed that medication-related worsening of cognition owes to dopamine overdose. We investigated whether age-related changes in baseline dopamine levels would modulate effects of dopaminergic therapy on reward learning in healthy volunteers. In a double-blind, crossover design, healthy younger and older adults completed a probabilistic reversal learning task after treatment with 100/25 mg of levodopa/carbidopa versus placebo. Older adults learned more poorly than younger adults at baseline, being more likely to shift responses after misleading punishment. Levodopa worsened stimulus-reward learning relative to placebo to the same extent in both groups, irrespective of differences in baseline performance and expected dopamine levels. When order effects were eliminated, levodopa induced response shifts after reward more often than placebo. Our results reveal independent deleterious effects of age group and exogenous dopamine on reward learning, suggesting a more complex scenario than predicted by the dopamine overdose hypothesis.
Keywords: Aging; Dopamine; Levodopa; Reversal learning; Reward; Striatum.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Levodopa impairs probabilistic reversal learning in healthy young adults.Psychopharmacology (Berl). 2016 Jul;233(14):2753-63. doi: 10.1007/s00213-016-4322-x. Epub 2016 May 30. Psychopharmacology (Berl). 2016. PMID: 27241710 Clinical Trial.
-
Effects of levodopa on stimulus-response learning versus response selection in healthy young adults.Behav Brain Res. 2017 Jan 15;317:553-561. doi: 10.1016/j.bbr.2016.10.019. Epub 2016 Oct 12. Behav Brain Res. 2017. PMID: 27743941 Clinical Trial.
-
Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration.J Neurosci. 2009 Feb 4;29(5):1538-43. doi: 10.1523/JNEUROSCI.4467-08.2009. J Neurosci. 2009. PMID: 19193900 Free PMC article. Clinical Trial.
-
Initiating therapy for Parkinson's disease.Neurology. 1998 Jun;50(6 Suppl 6):S18-22; discussion S44-8. doi: 10.1212/wnl.50.6_suppl_6.s18. Neurology. 1998. PMID: 9633682 Review.
-
Does levodopa slow or hasten the rate of progression of Parkinson's disease?J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42. doi: 10.1007/s00415-005-4008-5. J Neurol. 2005. PMID: 16222436 Review.
Cited by
-
Reversal learning is influenced by cognitive flexibility and develops throughout early adolescence.NPJ Sci Learn. 2025 May 12;10(1):27. doi: 10.1038/s41539-025-00308-3. NPJ Sci Learn. 2025. PMID: 40355441 Free PMC article.
-
L-DOPA and oxytocin influence the neural correlates of performance monitoring for self and others.Psychopharmacology (Berl). 2024 May;241(5):1079-1092. doi: 10.1007/s00213-024-06541-9. Epub 2024 Jan 29. Psychopharmacology (Berl). 2024. PMID: 38286857 Free PMC article. Clinical Trial.
-
Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson's disease: does the levodopa overdose hypothesis extend to gait?J Neurol. 2021 Feb;268(2):658-668. doi: 10.1007/s00415-020-10089-x. Epub 2020 Sep 9. J Neurol. 2021. PMID: 32902733
-
Decision making in Parkinson's disease: An analysis of the studies using the Iowa Gambling Task.Eur J Neurosci. 2021 Nov;54(10):7513-7549. doi: 10.1111/ejn.15497. Epub 2021 Nov 9. Eur J Neurosci. 2021. PMID: 34655122 Free PMC article. Review.
-
Exploring the effects of dopamine on sensorimotor inhibition and mobility in older adults.Exp Brain Res. 2023 Jan;241(1):127-133. doi: 10.1007/s00221-022-06509-1. Epub 2022 Nov 17. Exp Brain Res. 2023. PMID: 36394592 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical